- List
- By Topic
- On Map
- Search Details

"Persistent Hyperinsulinemia Hypoglycemia of Infancy" OR "familial hyperinsulinism"
Need help? See RSS Feeds
Choose a feed type:

"Persistent Hyperinsulinemia Hypoglycemia of Infancy" OR "familial hyperinsulinism" (28 records)
Need help? See Downloading Content for Analysis
For Advanced Users: Full Study Record XML Download
1 | NCT02604485 | Completed | A Single-Dose Open-Label Study of XOMA 358 in Subjects With Congenital Hyperinsulinism |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
10 | All | 18 Years and older (Adult, Senior) | NCT02604485 | X358602 | October 2015 | January 2017 | January 2017 | November 13, 2015 | February 6, 2017 |
|
||
2 | NCT02021604 | Recruiting | Fluorodopa F 18 in Congenital Hyperinsulinism |
|
|
Interventional | Phase 1 |
|
Other |
|
|
50 | All | up to 18 Years (Child, Adult) | NCT02021604 | 2012-060 | December 2013 | January 2019 | June 2019 | December 27, 2013 | September 1, 2017 |
|
||
3 | NCT02685852 | Recruiting | A Pilot Study Evaluating Exenatide for the Treatment of Postprandial Hyperinsulinemic Hypoglycemia Post-RYGB |
|
|
Interventional | Phase 2 |
|
Other |
|
|
12 | All | 18 Years to 60 Years (Adult) | NCT02685852 | 1503M65841 | February 2016 | April 2018 | April 2018 | February 19, 2016 | November 6, 2017 |
|
||
4 | NCT02937558 | Recruiting | CSI-Glucagon for Prevention of Hypoglycemia in Children With Congenital Hyperinsulinism |
|
|
Interventional | Phase 2 |
|
Industry / NIH |
|
|
12 | All | up to 12 Months (Child) | NCT02937558 | XSGO-CH01 1R44DK105691-01 |
October 2016 | May 2018 | June 2018 | October 18, 2016 | October 17, 2017 |
|
||
5 | NCT01070758 | Unknown † | Lanreotide Autogel Treatment of Patients With Congenital Hyperinsulinism of Infancy |
|
|
Interventional | Phase 4 |
|
Other |
|
|
10 | All | 2 Years to 8 Years (Child) | NCT01070758 | SHEBA-10-7165-DM-CTIL | February 2010 | February 2015 | February 2015 | February 18, 2010 | December 13, 2012 |
|
||
6 | NCT02108730 | Completed | Towards Individualized Surgery in Non-focal Congenital Hyperinsulinism |
|
|
Observational |
|
Other |
|
|
14 | All | Child, Adult, Senior | NCT02108730 | 123456 | non-focal CHI | March 2011 | March 2014 | March 2014 | April 9, 2014 | April 9, 2014 |
|
||
7 | NCT03103009 | Recruiting | Treatment Plan for an Individual Patient With Pasireotide for Hyperinsulinemic Hypoglycemia |
|
|
Interventional | Phase 1 |
|
Other / Industry |
|
|
1 | All | 18 Years and older (Adult, Senior) | NCT03103009 | 16-0393 | March 22, 2017 | March 22, 2019 | March 22, 2019 | April 6, 2017 | April 11, 2017 |
|
||
8 | NCT00571324 | Completed Has Results |
Effect of Exendin-(9-39) on Glycemic Control in Subjects With Congenital Hyperinsulinism |
|
|
Interventional | Phase 1 Phase 2 |
|
Other / NIH |
|
|
9 | All | 7 Years to 60 Years (Child, Adult) | NCT00571324 | 2007-1-5131 R03DK078535-01 |
August 2007 | December 2014 | December 2014 | December 12, 2007 | December 11, 2017 | November 9, 2016 |
|
|
9 | NCT01468454 | Completed | Phase II Safety and Efficacy Study of F-DOPA PET/CT in Children With Hyperinsulinemic Hypoglycemia |
|
|
Interventional | Phase 2 |
|
Other |
|
|
128 | All | Child, Adult, Senior | NCT01468454 | 08-006211 | F-DOPA PET | January 2009 | June 2014 | February 2018 | November 9, 2011 | February 19, 2018 |
|
|
10 | NCT02533219 | Available | Study of the Use of [18F]-DOPA in Hyperinsulinemic Hypoglycemia |
|
|
Expanded Access |
|
Other | All | up to 64 Years (Child, Adult) | NCT02533219 | H-32432 | [18F]-DOPA | August 26, 2015 | October 12, 2016 |
|
||||||||
11 | NCT01933490 | Completed | Post-Gastric Bypass Hypoglycemia |
|
|
Interventional | Not Applicable |
|
Other |
|
|
10 | All | 21 Years and older (Adult, Senior) | NCT01933490 | 21849 | August 2013 | August 2014 | August 2014 | September 2, 2013 | November 17, 2015 |
|
||
12 | NCT00897676 | Completed Has Results |
Effect of Exendin-(9-39) on Fasting Adaptation and Protein Sensitivity |
|
|
Interventional | Phase 1 Phase 2 |
|
Other |
|
|
17 | All | 6 Months to 18 Years (Child, Adult) | NCT00897676 | 2008-10-6255 R01FD004905 |
May 2009 | August 26, 2016 | January 2017 | May 12, 2009 | January 18, 2018 | January 18, 2018 |
|
|
13 | NCT03053284 | Not yet recruiting | Pasireotide in Hyperinsulinemic Hypoglycemia |
|
|
Interventional | Phase 2 |
|
Other / Industry |
|
|
4 | All | 18 Years to 70 Years (Adult, Senior) | NCT03053284 | 2016-7044 | April 2017 | January 2018 | April 2018 | February 15, 2017 | February 15, 2017 | |||
14 | NCT00835328 | Recruiting | Effect of Exendin-(9-39) On Glucose Requirements To Maintain Euglycemia |
|
|
Interventional | Phase 1 Phase 2 |
|
Other |
|
|
20 | All | up to 12 Months (Child) | NCT00835328 | 2008-10-6256 | February 2009 | February 2019 | September 2019 | February 3, 2009 | March 9, 2018 |
|
||
15 | NCT01916148 | Available | 18F-L-Fluoro-DOPA PET/CT Scan Localization of Focal Pancreatic Lesions in Subjects With Hyperinsulinemic Hypoglycemia |
|
|
Expanded Access |
|
Other | All | Child, Adult, Senior | NCT01916148 | 12-009528 | August 5, 2013 | February 16, 2018 |
|
|||||||||
16 | NCT00987168 | Completed | Sandostatine® LP and Hyperinsulinism |
|
|
Interventional | Phase 2 |
|
Other / Industry |
|
|
10 | All | 6 Months to 16 Years (Child) | NCT00987168 | CRC 07024 | May 2009 | April 2011 | June 2011 | September 30, 2009 | December 19, 2013 |
|
||
17 | NCT02835131 | Available | Compassionate Use of SOM230 for Hyperinsulinemic/Hypoglycemia |
|
|
Expanded Access |
|
Other | All | 18 Years to 90 Years (Adult, Senior) | NCT02835131 | 2015-5564 | July 15, 2016 | July 15, 2016 |
|
|||||||||
18 | NCT01819584 | Unknown † | Long Term Glucose Metabolism in Conservatively Treated Patients With Congenital Hyperinsulinism |
|
Observational |
|
Other |
|
|
30 | All | Child, Adult, Senior | NCT01819584 | SHEBA-12-9794-KM-CTIL | April 2013 | December 2014 | December 2015 | March 27, 2013 | March 27, 2013 | |||||
19 | NCT02127541 | Completed | New Imaging Procedure for the Localisation of Insulinoma |
|
|
Interventional | Not Applicable |
|
Other |
|
|
52 | All | 18 Years and older (Adult, Senior) | NCT02127541 | EKBB 163/12 | January 6, 2014 | November 2017 | November 2017 | April 30, 2014 | April 18, 2018 |
|
||
20 | NCT00674440 | Completed | Utility of [F-18] fluoroDOPA for Neonatal Hyperinsulinism |
|
|
Interventional | Phase 2 |
|
Other |
|
|
105 | All | up to 18 Years (Child, Adult) | NCT00674440 | 04-003683 FD-R-003457-01 |
December 2004 | December 2008 | February 2018 | May 7, 2008 | February 19, 2018 |
|
||
21 | NCT02524639 | Recruiting | Sirolimus for the Treatment of Hyperinsulinism |
|
|
Interventional | Phase 1 Phase 2 |
|
Other |
|
|
6 | All | up to 12 Months (Child) | NCT02524639 | 15-011973 | August 2015 | June 2018 | June 2018 | August 17, 2015 | October 17, 2017 |
|
||
22 | NCT03303196 | Not yet recruiting | Bionic Pancreas in Children With Hyperinsulinism and Post-Pancreatectomy Diabetes |
|
|
Interventional | Not Applicable |
|
Other |
|
|
7 | All | 6 Years to 30 Years (Child, Adult) | NCT03303196 | 17-014144 | April 2018 | December 2018 | December 2018 | October 5, 2017 | February 13, 2018 | |||
23 | NCT02550145 | Unknown † | Role of GLP-1 in Hyperinsulinemic Hypoglycemia Post-bariatric Surgery |
|
|
Interventional | Phase 1 |
|
Other |
|
|
30 | All | 18 Years to 65 Years (Adult) | NCT02550145 | 29010 | February 2014 | December 2016 | September 15, 2015 | July 4, 2016 |
|
|||
24 | NCT03182192 | Recruiting | GLP1R-imaging in Hypoglycemia |
|
|
Interventional | Phase 1 |
|
Other |
|
|
12 | All | 18 Years and older (Adult, Senior) | NCT03182192 | NL51854.091.15 | April 1, 2016 | January 1, 2018 | May 1, 2018 | June 9, 2017 | June 16, 2017 |
|
||
25 | NCT02996812 | Active, not recruiting | Evaluation of Single Ascending Doses of Subcutaneous Exendin 9-39 in Patients With Post-Bariatric Hypoglycemia |
|
|
Interventional | Phase 1 |
|
Other |
|
|
9 | All | 18 Years to 65 Years (Adult) | NCT02996812 | 34054 | April 2015 | May 2016 | May 2017 | December 19, 2016 | December 19, 2016 |
|
||
26 | NCT02771574 | Recruiting | Efficacy, Tolerability and Pharmacokinetics of Subcutaneous Exendin (9-39) in Patients With Post Bariatric Hypoglycemia |
|
|
Interventional | Phase 2 |
|
Other |
|
|
16 | All | 18 Years to 70 Years (Adult, Senior) | NCT02771574 | 36673 | May 2016 | November 2016 | May 2017 | May 13, 2016 | May 13, 2016 |
|
||
27 | NCT03042416 | Recruiting | 18F-DOPA PET Imaging: an Evaluation of Biodistribution and Safety |
|
|
Interventional | Phase 3 |
|
Other |
|
|
400 | All | Child, Adult, Senior | NCT03042416 | Pro00055342 | June 29, 2017 | December 31, 2021 | December 31, 2022 | February 3, 2017 | October 26, 2017 |
|
||
28 | NCT02560376 | Unknown † | 68Ga-NOTA-exendin-4 PET/CT for the Localization of Insulinoma and Diagnosis of Nesidioblastosis |
|
|
Interventional | Early Phase 1 |
|
Other / NIH |
|
|
100 | All | 6 Years to 70 Years (Child, Adult, Senior) | NCT02560376 | PUMCHNM12 ZIAEB000073 |
February 2014 | December 2016 | December 2016 | September 25, 2015 | September 25, 2015 |
|
† Study has passed its completion date and status has not been verified in more than two years.